Lisa Wahlström
Datos Biográficos
| ID | 7979678 |
|---|---|
| NOMBRE | Lisa Wahlström |
| NOMBRES | Lisa |
| APELLIDO | Wahlström |
| FIRMA | WAHLSTRÖM L |
| AFILIACIONES | Sunderby sjukhus |
| VERIFICADO | No |
| TOTAL DE OBRAS | 1 |
| TOTAL DE CITAS | 0 |
| TOTAL COMO AUTOR | 1 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2024 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2024 |
| ÍNDICE H | 0 |
Serious adverse drug events associated with psychotropic treatment of bipolar or schizoaffective disorder
Serious ADEs related to treatment of bipolar (BD) or schizoaffective disorder (SZD) were uncommon but not rare. Older individuals were particularly at risk. The risk was higher in individuals exposed to lithium. Serum lithium concentration should always be checked when patients present with new or unclear somatic symptoms. However, severe ADEs also occurred with other mood stabilisers and other psychotropic drugs
Sin obras prominentes en esta página.
Serious adverse drug events associated with psychotropic treatment of bipolar or schizoaffective disorder
Serious ADEs related to treatment of bipolar (BD) or schizoaffective disorder (SZD) were uncommon but not rare. Older individuals were particularly at risk. The risk was higher in individuals exposed to lithium. Serum lithium concentration should always be checked when patients present with new or unclear somatic symptoms. However, severe ADEs also occurred with other mood stabilisers and other psychotropic drugs
Adverse effect (1 obra) · Bipolar disorder (1 obra) · Bipolar Disorder and Treatment (1 obra) · Cohort (1 obra) · Cohort study (1 obra) · Confidence interval (1 obra) · Electroconvulsive Therapy Studies (1 obra) · Incidence (geometry (1 obra) · Internal Medicine (1 obra) · Lithium (medication (1 obra)